tiprankstipranks
Trending News
More News >

ResMed CFO Executes Stock Transaction Under Rule 10b5-1 Plan

Story Highlights
ResMed CFO Executes Stock Transaction Under Rule 10b5-1 Plan

Confident Investing Starts Here:

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an update.

ResMed Inc. has reported a change in beneficial ownership, with Chief Financial Officer Brett Sandercock executing a transaction involving the sale of 3,644 shares of ResMed common stock at a price of $244.59 per share. This transaction was conducted under a pre-established Rule 10b5-1 plan, highlighting a strategic financial decision within the company’s management. The transaction reflects ongoing management activities and may influence stakeholder perceptions regarding the company’s financial strategies.

The most recent analyst rating on (AU:RMD) stock is a Buy with a A$33.70 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.

More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

ResMed Inc. operates in the healthcare industry, specializing in the development and manufacturing of products for the treatment of sleep disorders, particularly sleep apnea. The company is known for its innovative solutions and devices that aim to improve the quality of life for individuals with respiratory conditions.

Average Trading Volume: 1,368,799

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$54.91B

For an in-depth examination of RMD stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App